ITI Pharma and Healthcare Fund - Regular Plan - Growth Option
NAV: as on:
MIn SIP Amount: 500
Rating: Not Rated
Fund Size: 183.3861
SIP Amount
₹
Frequency
SIP Start Date
Holdings
Name Sector Instrument Type Assets(%)
Sun Pharmaceutical Industries Ltd Pharmaceuticals -- 15.97
Sun Pharmaceutical Industries Ltd Pharmaceuticals -- 15.97
Sun Pharmaceutical Industries Ltd Pharmaceuticals -- 15.97
Dr. Reddy'S Laboratories Ltd Pharmaceuticals -- 7.2
Dr. Reddy'S Laboratories Ltd Pharmaceuticals -- 7.2
Dr. Reddy'S Laboratories Ltd Pharmaceuticals -- 7.2
Lupin Ltd Pharmaceuticals -- 6.39
Lupin Ltd Pharmaceuticals -- 6.39
Lupin Ltd Pharmaceuticals -- 6.39
Apollo Hospitals Enterprises Ltd Health Care -- 5.63
Apollo Hospitals Enterprises Ltd Health Care -- 5.63
Apollo Hospitals Enterprises Ltd Health Care -- 5.63
Suven Pharmaceuticals Ltd Pharmaceuticals -- 5.49
Suven Pharmaceuticals Ltd Pharmaceuticals -- 5.49
Suven Pharmaceuticals Ltd Pharmaceuticals -- 5.49
Divi'S Laboratories Ltd Pharmaceuticals -- 4.49
Divi'S Laboratories Ltd Pharmaceuticals -- 4.49
Divi'S Laboratories Ltd Pharmaceuticals -- 4.49
Zydus Lifesciences Ltd Pharmaceuticals -- 4.18
Zydus Lifesciences Ltd Pharmaceuticals -- 4.18
Zydus Lifesciences Ltd Pharmaceuticals -- 4.18
Max Healthcare Institute Ltd Health Care -- 3.31
Max Healthcare Institute Ltd Health Care -- 3.31
Max Healthcare Institute Ltd Health Care -- 3.31
Cipla Ltd Pharmaceuticals -- 3.15
Cipla Ltd Pharmaceuticals -- 3.15
Cipla Ltd Pharmaceuticals -- 3.15
Laurus Labs Ltd Pharmaceuticals -- 2.91
Laurus Labs Ltd Pharmaceuticals -- 2.91
Laurus Labs Ltd Pharmaceuticals -- 2.91
Syngene International Ltd Health Care -- 2.65
Syngene International Ltd Health Care -- 2.65
Syngene International Ltd Health Care -- 2.65
Torrent Pharmaceuticals Ltd Pharmaceuticals -- 2.48
Torrent Pharmaceuticals Ltd Pharmaceuticals -- 2.48
Torrent Pharmaceuticals Ltd Pharmaceuticals -- 2.48
Alembic Pharmaceuticals Ltd Pharmaceuticals -- 2.11
Alembic Pharmaceuticals Ltd Pharmaceuticals -- 2.11
Alembic Pharmaceuticals Ltd Pharmaceuticals -- 2.11
Archean Chemical Industries Ltd Chemicals -- 2.02
Archean Chemical Industries Ltd Chemicals -- 2.02
Archean Chemical Industries Ltd Chemicals -- 2.02
Piramal Pharma Ltd Pharmaceuticals -- 1.99
Piramal Pharma Ltd Pharmaceuticals -- 1.99
Piramal Pharma Ltd Pharmaceuticals -- 1.99
Orchid Pharma Ltd Pharmaceuticals -- 1.98
Orchid Pharma Ltd Pharmaceuticals -- 1.98
Orchid Pharma Ltd Pharmaceuticals -- 1.98
FDC Ltd Pharmaceuticals -- 1.79
FDC Ltd Pharmaceuticals -- 1.79
FDC Ltd Pharmaceuticals -- 1.79
Aurobindo Pharma Ltd Pharmaceuticals -- 1.78
Aurobindo Pharma Ltd Pharmaceuticals -- 1.78
Aurobindo Pharma Ltd Pharmaceuticals -- 1.78
Ipca Laboratories Ltd Pharmaceuticals -- 1.63
Ipca Laboratories Ltd Pharmaceuticals -- 1.63
Ipca Laboratories Ltd Pharmaceuticals -- 1.63
Healthcare Global Enterprises Ltd Health Care -- 1.53
Healthcare Global Enterprises Ltd Health Care -- 1.53
Healthcare Global Enterprises Ltd Health Care -- 1.53
Biocon Ltd Pharmaceuticals -- 1.39
Biocon Ltd Pharmaceuticals -- 1.39
Biocon Ltd Pharmaceuticals -- 1.39
Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals -- 1.37
Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals -- 1.37
Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals -- 1.37
Net Receivables / Payables Cash/Deposits/Margins/Treps/Repo/Swaps -- 1.36
Net Receivables / Payables Cash/Deposits/Margins/Treps/Repo/Swaps -- 1.36
Net Receivables / Payables Cash/Deposits/Margins/Treps/Repo/Swaps -- 1.36
Ajanta Pharma Ltd Pharmaceuticals -- 1.34
Ajanta Pharma Ltd Pharmaceuticals -- 1.34
Ajanta Pharma Ltd Pharmaceuticals -- 1.34
Mankind Pharma Ltd Pharmaceuticals -- 1.33
Mankind Pharma Ltd Pharmaceuticals -- 1.33
Mankind Pharma Ltd Pharmaceuticals -- 1.33
Vijaya Diagnostic Centre Ltd Health Care -- 1.3
Vijaya Diagnostic Centre Ltd Health Care -- 1.3
Vijaya Diagnostic Centre Ltd Health Care -- 1.3
Caplin Point Laboratories Ltd Pharmaceuticals -- 1.27
Caplin Point Laboratories Ltd Pharmaceuticals -- 1.27
Caplin Point Laboratories Ltd Pharmaceuticals -- 1.27
Abbott India Ltd Pharmaceuticals -- 1.13
Abbott India Ltd Pharmaceuticals -- 1.13
Abbott India Ltd Pharmaceuticals -- 1.13
Sumitomo Chemical India Ltd Fertilizers -- 1.06
Sumitomo Chemical India Ltd Fertilizers -- 1.06
Sumitomo Chemical India Ltd Fertilizers -- 1.06
JB Chemicals & Pharmaceuticals Ltd Pharmaceuticals -- 1.04
JB Chemicals & Pharmaceuticals Ltd Pharmaceuticals -- 1.04
JB Chemicals & Pharmaceuticals Ltd Pharmaceuticals -- 1.04
Shilpa Medicare Ltd Pharmaceuticals -- 1.01
Shilpa Medicare Ltd Pharmaceuticals -- 1.01
Shilpa Medicare Ltd Pharmaceuticals -- 1.01
Fortis Healthcare Ltd Health Care -- 0.98
Fortis Healthcare Ltd Health Care -- 0.98
Fortis Healthcare Ltd Health Care -- 0.98
Alkem Laboratories Ltd Pharmaceuticals -- 0.94
Alkem Laboratories Ltd Pharmaceuticals -- 0.94
Alkem Laboratories Ltd Pharmaceuticals -- 0.94
Rainbow Children'S Medicare Ltd Health Care -- 0.94
Rainbow Children'S Medicare Ltd Health Care -- 0.94
Rainbow Children'S Medicare Ltd Health Care -- 0.94
Gland Pharma Ltd Pharmaceuticals -- 0.93
Gland Pharma Ltd Pharmaceuticals -- 0.93
Gland Pharma Ltd Pharmaceuticals -- 0.93
Strides Pharma Science Ltd Pharmaceuticals -- 0.86
Strides Pharma Science Ltd Pharmaceuticals -- 0.86
Strides Pharma Science Ltd Pharmaceuticals -- 0.86
Wockhardt Ltd Pharmaceuticals -- 0.74
Wockhardt Ltd Pharmaceuticals -- 0.74
Wockhardt Ltd Pharmaceuticals -- 0.74
Sanofi India Ltd Pharmaceuticals -- 0.7
Sanofi India Ltd Pharmaceuticals -- 0.7
Sanofi India Ltd Pharmaceuticals -- 0.7
Emcure Pharmaceuticals Ltd Pharmaceuticals -- 0.67
Emcure Pharmaceuticals Ltd Pharmaceuticals -- 0.67
Emcure Pharmaceuticals Ltd Pharmaceuticals -- 0.67
Supriya Lifescience Ltd Pharmaceuticals -- 0.56
Supriya Lifescience Ltd Pharmaceuticals -- 0.56
Supriya Lifescience Ltd Pharmaceuticals -- 0.56
Sanofi Consumer Healthcare India Ltd Pharmaceuticals & Biotechnology -- 0.4
Sanofi Consumer Healthcare India Ltd Pharmaceuticals & Biotechnology -- 0.4
Sanofi Consumer Healthcare India Ltd Pharmaceuticals & Biotechnology -- 0.4
Holding analysis
Asset Class Percentage
Equity 98.6464
Debt 0
Cash
Equity sector allocation
Pharmaceuticals
Health Care
Chemicals
Cash/Deposits/Margins/Treps/Repo/Swaps
Fertilizers
Pharmaceuticals & Biotechnology
236.46
49.02
6.06
4.08
3.18
1.2
Sector Holding Percentage
Pharmaceuticals 236.46
Health Care 49.02
Chemicals 6.06
Cash/Deposits/Margins/Treps/Repo/Swaps 4.08
Fertilizers 3.18
Pharmaceuticals & Biotechnology 1.2
Advanced Ratios
Standard Dev. 13.0576
P/E Ratio 56.3814
Sharpe -0.8237
Alpha 2.8958
Beta 0.9788
Sortino 0.441
Minimum Investment Amounts
Minimum for 1st Investment 5000
Minimum for SIP 500
Returns and rankings
Category : Equity
Annualised returns
1Y 3Y 5Y
Fund returns 53.31
Category average -9.1 23.3 12.4
Rank with in category 0 9 9
Expense ratio:2.34

Inclusive of GST

Exit load

1% on or before 12M, Nil after 12M

Stamp duty

0.005% (from July 1st, 2020)

Tax implication

Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.

Fund house & investment objective
Rank (total assets) ---
Total AUM ₹8,764.83Cr
Date of Incorporation ---

Investment Objective

The Investment Objective Of The Scheme Is To Seek To Generate Long Term Capital Appreciation Throughinvesting In Equity And Equity Related Securities Of Companies Engaged In Pharma And Healthcare.However, There Can Be No Assurance Or Guarantee That The Investment Objective Of The Scheme Would Be Achieved.

Fund benchmark NIFTY Healthcare Index
Scheme Information Document(SID)
Fund house contact details
Address: Naman Midtown, A - Wing, 21st Floor, Senapati Bapat Marg, Elphinstone Road
Mumbai - 400 013
Phone:--------
Launch Date:--------
E-mail: mfassist@itiorg.com
Website: http://www.itimf.com/
ITI Asset Management Limited
Custodian:Deutsche Bank
Registrar & Transfer Agent:Karvy
Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai,
E-mail: enq_h@camsonline.com
enq_h@camsonline.com
Website: www.camsonline.com
Compare funds
Funds Comparison
Fund management
Rohan Korde
Jan 2013 - Present